Latest Strategic Partnerships News

Page 47 of 284
ReNerve Limited reported a half-year loss of $2.72 million, up 47% from last year, as it expands its nerve repair product portfolio and secures new regulatory approvals in Asia-Pacific.
Ada Torres
Ada Torres
26 Feb 2026
Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.
Victor Sage
Victor Sage
26 Feb 2026
Lynas Rare Earths Ltd has reported a striking half-year turnaround with a 1260% surge in net profit, underpinned by rising rare earth prices and strategic expansions. The company also completed a major equity raise to fuel its ambitious Towards 2030 growth plan.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Airtasker Limited reports a strong HY26 with positive operating cash flow and robust international revenue growth, led by explosive gains in the US and UK marketplaces.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Smartgroup Corporation Ltd reported robust 2025 results, driven by digital innovation, expanding customer base, and a strengthened sustainability strategy. The company declared generous dividends and outlined a confident outlook for continued margin expansion.
Claire Turing
Claire Turing
26 Feb 2026
Riversgold has dramatically expanded its Kalgoorlie Gold Project tenements by over 800%, positioning itself for long-term development with a new mining agreement that shares funding and profits with MEGA Resources.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Tungsten Mining is pursuing a US stock exchange listing to tap into deeper capital markets and strengthen ties with US government and industry stakeholders, complementing its existing ASX listing.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Alcidion Group Limited has reported a robust half-year performance with a 44% revenue increase and a return to profitability, driven by key contract expansions and new wins in the UK and Australia. The company is now positioned to secure a major Electronic Patient Record contract with University Hospitals Sussex NHS Foundation Trust.
Victor Sage
Victor Sage
26 Feb 2026
NeuroScientific Biopharmaceuticals reported a $1.7 million loss for the half-year ending December 2025, driven by ongoing R&D investments. The company progressed clinical treatments for Crohn’s disease and glaucoma, alongside key leadership appointments and strategic partnerships.
Ada Torres
Ada Torres
25 Feb 2026
Cleo Diagnostics reported a 53% drop in revenues and a slight increase in net loss to $1.98 million for H1 2025, while progressing its pivotal FDA clinical trial for an ovarian cancer blood test with strong regulatory and commercial milestones.
Ada Torres
Ada Torres
25 Feb 2026
Global Health Limited reports a modest half-year loss reduction alongside a steady rise in recurring SaaS revenue, signaling progress in its digital healthcare transformation.
Sophie Babbage
Sophie Babbage
25 Feb 2026
HITIQ Limited reported a $2.9 million loss for the half-year ending December 2025, while making significant strides in international market expansion and strategic partnerships. The company’s capital raising efforts aim to support its transition from technology validation to commercial execution.
Sophie Babbage
Sophie Babbage
25 Feb 2026